AI assistant
Sending…
Ernexa Therapeutics Inc. — Director's Dealing 2012
Sep 10, 2012
35259_dirs_2012-09-10_78e4cc34-f42c-4da1-936b-08de0f800128.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2012-09-10
Reporting Person: Berg Jeffrey Alan (Director, INTERIM CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-10 | Common Stock | P | 1110684 | $0.17 | Acquired | 17153758 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Direct |
Footnotes
F1: These securities were purchased and are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein
More from Ernexa Therapeutics Inc.
Major Shareholding Notification
2026
May 14
Annual Report
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Interim / Quarterly Report
2026
May 11
Share Issue/Capital Change
2026
May 4
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 24